Microbot Medical Inc
MBOT2.215USD
+0.135+6.49%
Market hours （ET）Quotes delayed by 15 min
145.82MMarket Cap
LossP/E TTM
More Details of Microbot Medical Inc Company
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Microbot Medical Inc Info
Ticker SymbolMBOT
Company nameMicrobot Medical Inc
IPO dateMar 25, 1992
CEOGadot (Harel)
Number of employees21
Security typeOrdinary Share
Fiscal year-endMar 25
Address175 Derby St Bld 27
CityHINGHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code02043
Phone17818753605
Websitehttp://www.microbotmedical.com/
Ticker SymbolMBOT
IPO dateMar 25, 1992
CEOGadot (Harel)
Company Executives of Microbot Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Nov 25
Updated: Tue, Nov 25
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
3.49%
CIBC Private Wealth Management
2.17%
Susquehanna International Group, LLP
1.86%
Heights Capital Management, Inc.
1.31%
Geode Capital Management, L.L.C.
0.73%
Other
90.43%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
3.49%
CIBC Private Wealth Management
2.17%
Susquehanna International Group, LLP
1.86%
Heights Capital Management, Inc.
1.31%
Geode Capital Management, L.L.C.
0.73%
Other
90.43%
Shareholder Types
Shareholders
Proportion
Investment Advisor
8.12%
Investment Advisor/Hedge Fund
4.56%
Research Firm
0.49%
Hedge Fund
0.43%
Venture Capital
0.20%
Bank and Trust
0.04%
Other
86.16%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
108
5.08M
9.55%
-906.12K
2025Q2
93
3.71M
8.26%
-749.31K
2025Q1
89
2.58M
7.86%
-1.62M
2024Q4
78
1.58M
4.97%
-880.54K
2024Q3
70
1.52M
8.93%
-946.72K
2024Q2
71
1.56M
9.80%
-833.62K
2024Q1
69
2.54M
18.61%
-153.32K
2023Q4
67
2.61M
22.30%
+489.30K
2023Q3
65
2.09M
17.88%
-264.50K
2023Q2
64
2.33M
23.62%
-218.94K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
2.05M
3.86%
+1.31M
+176.68%
Jun 30, 2025
CIBC Private Wealth Management
612.00K
1.15%
+612.00K
--
Jun 30, 2025
Susquehanna International Group, LLP
31.84K
0.06%
-72.34K
-69.44%
Jun 30, 2025
Geode Capital Management, L.L.C.
395.04K
0.74%
+78.12K
+24.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
313.96K
0.59%
+77.85K
+32.97%
Jun 30, 2025
DNB Asset Management AS
192.79K
0.36%
+77.97K
+67.90%
Jun 30, 2025
State Street Investment Management (US)
138.52K
0.26%
+1.85K
+1.35%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
Avantis US Small Cap Equity ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Microbot Medical Inc?
The top five shareholders of Microbot Medical Inc are:
The Vanguard Group, Inc. holds 2.05M shares, accounting for 3.86% of the total shares.
CIBC Private Wealth Management holds 612.00K shares, accounting for 1.15% of the total shares.
Susquehanna International Group, LLP holds 31.84K shares, accounting for 0.06% of the total shares.
Geode Capital Management, L.L.C. holds 395.04K shares, accounting for 0.74% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 313.96K shares, accounting for 0.59% of the total shares.
The Vanguard Group, Inc. holds 2.05M shares, accounting for 3.86% of the total shares.
CIBC Private Wealth Management holds 612.00K shares, accounting for 1.15% of the total shares.
Susquehanna International Group, LLP holds 31.84K shares, accounting for 0.06% of the total shares.
Geode Capital Management, L.L.C. holds 395.04K shares, accounting for 0.74% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 313.96K shares, accounting for 0.59% of the total shares.
What are the top three shareholder types of Microbot Medical Inc?
The top three shareholder types of Microbot Medical Inc are:
The Vanguard Group, Inc.
CIBC Private Wealth Management
Susquehanna International Group, LLP
The Vanguard Group, Inc.
CIBC Private Wealth Management
Susquehanna International Group, LLP
How many institutions hold shares of Microbot Medical Inc (MBOT)?
As of 2025Q3, 108 institutions hold shares of Microbot Medical Inc, with a combined market value of approximately 5.08M, accounting for 9.55% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 1.29%.
What is the biggest source of revenue for Microbot Medical Inc?
In --, the -- business generated the highest revenue for Microbot Medical Inc, amounting to -- and accounting for --% of total revenue.
